Gene · 7939
Papers2,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Three-Dimensional Digital Light-Processing Bioprinting Using Silk Fibroin-Based Bio-Ink: Recent Advancements in Biomedical Applications. | Biomedicines | 2022 | 36551978 | PubTator, text mining | PubMed |
| Hydrogel-Encapsulated Heterogenous Mesoporous Resin Catalyst for In Situ Anti-Cancer Agent Production under Biological Conditions. | Biomolecules | 2022 | 36551224 | PubTator, text mining | PubMed |
| Methacrylated Silk Fibroin Additive Manufacturing of Shape Memory Constructs with Possible Application in Bone Regeneration. | Gels | 2022 | 36547356 | PubTator, text mining | PubMed |
| TGFβ+ small extracellular vesicles from head and neck squamous cell carcinoma cells reprogram macrophages towards a pro-angiogenic phenotype. | J Extracell Vesicles | 2022 | 36537293 | PubTator, text mining | PubMed |
| Microfluidic SERS devices: brightening the future of bioanalysis. | Discov Mater | 2022 | 36536830 | PubTator, text mining | PubMed |
| 3D-bioprinted, phototunable hydrogel models for studying adventitial fibroblast activation in pulmonary arterial hypertension. | Biofabrication | 2022 | 36533728 | PubTator, text mining | PubMed |
| Extracellular Matrix Microparticles Improve GelMA Bioink Resolution for 3D Bioprinting at Ambient Temperature. | Macromol Mater Eng | 2022 | 36531127 | PubTator, text mining | PubMed |
| Comparison of longitudinal changes in four surrogate insulin resistance indexes for incident T2DM in middle-aged and elderly Chinese. | Front Public Health | 2022 | 36530691 | PubTator, text mining | PubMed |
| A review on cell damage, viability, and functionality during 3D bioprinting. | Mil Med Res | 2022 | 36522661 | PubTator, text mining | PubMed |
| Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects. | Front Immunol | 2022 | 36505477 | PubTator, text mining | PubMed |
| The prediction and verification of outcome of extracardiac conduits fontan based on computational fluid dynamics simulation. | Front Physiol | 2022 | 36505086 | PubTator, text mining | PubMed |
| Varietal Descriptors for the Distinction of Underutilized Varieties of Sechium edule (Jacq) Swartz. | Plants (Basel) | 2022 | 36501349 | PubTator, text mining | PubMed |
| Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019. | PLoS One | 2022 | 36490261 | PubTator, text mining | PubMed |
| The mechanisms underlying the immune control of Zika virus infection at the maternal-fetal interface. | Front Immunol | 2022 | 36483552 | PubTator, text mining | PubMed |
| The potential role of adherence factors in probiotic function in the gastrointestinal tract of adults and pediatrics: a narrative review of experimental and human studies. | Gut Microbes | 2022 | 36469568 | PubTator, text mining | PubMed |
| Inflammatory biomarkers after an exercise intervention in childhood acute lymphoblastic leukemia survivors. | EJHaem | 2022 | 36467791 | PubTator, text mining | PubMed |
| Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity. | Front Immunol | 2022 | 36439156 | PubTator, text mining | PubMed |
| Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead-A Systematic Review. | Int J Mol Sci | 2022 | 36430594 | PubTator, text mining | PubMed |
| Electrospun Azithromycin-Laden Gelatin Methacryloyl Fibers for Endodontic Infection Control. | Int J Mol Sci | 2022 | 36430238 | PubTator, text mining | PubMed |
| Obesity, Diabetes, and Cardiovascular Risk Burden in Systemic Lupus Erythematosus: Current Approaches and Knowledge Gaps-A Rapid Scoping Review. | Int J Environ Res Public Health | 2022 | 36429489 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7939/papers?page=34